Skip to main content
. 2020 Apr 8;15(4):e0230813. doi: 10.1371/journal.pone.0230813

Table 3. Features differentially expressed between control and LPS samples in cell and supernatant samples.

Feature m/z RT Ionization Mode Method Log2(Fold Change) Proposed molecular formula Proposed annotation Level ID Δppm
Intracellular
1 221.0919 18.5 Pos HILIC 2.3 C11H12N2O3 Hydroxy-tryptophan 3 1
2 299.2003 7.3 Pos HILIC 4.0 C20H26O2 3,4-didehydro-retinoate 3 1
3 301.2163 7.6 Pos HILIC 5.4 C20H28O2 4-hydroxyretinal 3 0
4 305.0864 14.8 Pos HILIC 1.2 C12H17O9 - 3 1
5 317.2112 7.9 Pos HILIC 4.4 C20H28O3 15-deoxy-PGJ2 3 0
6 319.2270 7.7 Pos HILIC 5.3 C20H30O3 Leukotriene A4 3 1
7 344.2438 18.4 Pos HILIC 3.7 C18H34NO5 4 2
8 393.2260 7.4 Pos HILIC 5.7 C22H32O6 10-hydroperoxy-H4-neuroprostane 3 3
9 120.0449 4.9 Neg HILIC 4.0 C7H7NO - 3 4
10 164.0346 4.9 Neg HILIC 3.8 C8H7NO3 Pyridoxolactone 3 4
11 167.0171 17.7 Neg HILIC 2.2 C2H5N3O6 - 4 7
12 194.0451 3.8 Neg HILIC 6.7 C9H9NO4 Hydroxyhippuric acid 3 4
13 315.1952 7.2 Neg HILIC 4.9 C20H28O3 15-deoxy-PGJ2 3 4
14 333.2061 7.1 Neg HILIC 8.7 C20H30O4 Prostaglandin A2 3 3
15 334.2095 5.2 Neg HILIC 5.0 C15H30N2O6 - 4 4
16 351.2160 7.1 Neg HILIC 4.8 C20H32O5 Thromboxane A2 3 5
17 353.2325 9.7 Neg HILIC 2.7 C20H34O5 Prostaglandin E1 3 2
18 368.2432 10.4 Neg HILIC 5.1 C18H30NO5 - 4 1
19 381.2632 8.9 Neg HILIC 10.3 C22H32N4O4 - 3 4
20 383.2425 5.1 Neg HILIC 5.5 C21H35O6 4 3
21 385.2217 14.9 Neg HILIC 2.8 C20H34O7 Dihydro-trihydroxy-leukotriene B4 3 4
22 436.1933 7.0 Neg HILIC 5.4 C18H26N7O6 - 4 3
23 387.1448 18.7 Pos RP 9.5 C21H22O7 - 3 3
24 134.1 12.40 - GC 8.4 C4H6O5 Malic acid 1
25 167.0 15.19 - GC 1.3 C7H5NO4 Quinolinic acid 1
Extracellular
1 136.0398 14.56 Pos HILIC 8.3 C7H5NO2 - 3
2 405.2630 7.25 Pos HILIC 3.4 C24H36O5 - 3
3 757.4305 7.60 Pos HILIC 6.3 C39H64O14 - 3
4 334.2115 6.0 Neg HILIC 3.9 C15H30N2O6 5 2
5 351.2190 6.79 Neg HILIC 3.6 C20H32O5 Prostaglandin E2 3